Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 3
2009 1
2010 3
2011 2
2012 1
2013 6
2014 4
2015 7
2016 3
2017 2
2018 2
2019 3
2020 5
2021 11
2022 5
2023 9
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Pathophysiology of sepsis-induced cholestasis: A review.
Ghenu MI, Dragoş D, Manea MM, Ionescu D, Negreanu L. Ghenu MI, et al. Among authors: negreanu l. JGH Open. 2022 May 25;6(6):378-387. doi: 10.1002/jgh3.12771. eCollection 2022 Jun. JGH Open. 2022. PMID: 35774351 Free PMC article. Review.
Portal hypertensive gastropathy.
Negreanu L, Buşegeanu C, Trandafir D, Dragomir P, Udeanu M, Fierbinţeanu-Braticevici C, Andronescu D. Negreanu L, et al. Rom J Intern Med. 2005;43(1-2):3-8. Rom J Intern Med. 2005. PMID: 16739861 Review.
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.
Shani U, State M, Mateescu RB, Davidoiu AM, Negreanu L, Silva I, Magro F, Lees CW, Plevris N, Roblin X, Castellet-Farrús S, Gonzalez Lama Y, Wang S, Abad C, Imperatore N, Lukas M, Vojtechova G, Ukashi O, Ben-Horin S, Nancey S, Savarino E, Stawczyk-Eder K, Eder P, Toskas A, Kamperidis N, Arebi N, Farkas B, Farkas K, Pipek B, Falt P, Karmiris K, Nikolaou P, Krznaric Z, Brinar M, Hoentjen F, van Lierop L, Barreiro-de Acosta M, Zaborowska M, Zagorowicz E, Pugliese D, Cuccia G, Truyens M, Kopylov U. Shani U, et al. Among authors: negreanu l. J Crohns Colitis. 2025 Jun 4;19(6):jjaf099. doi: 10.1093/ecco-jcc/jjaf099. J Crohns Colitis. 2025. PMID: 40490896
79 results